In order to launch her startup, Eydis Lima (‘18), applied to MassChallenge in Austin, TX. DermaDiagnostics, is a startup with a mission of creating a platform for healthcare facilities wherein a dermal patch will be able to diagnose sexually transmitted infections (STIs) and cervical cancer. Globally, on an annual basis the burden altogether of these malignancies is affecting 550 million individuals. The focus of the company is to provide a technology that allows in a non-invasive manner diagnosis to help the most susceptible: young adults and pregnant women.
There were 527 companies that applied to MassChallenge, 281 were invited to pitch, and now 84 are finalists, one of which is Eydis with DermaDiagnostics. Being a finalists means that Eydis will be moving to Austin after graduation where she will be in an incubator and have access to resources to further the stage of her company. Some of these resources include office and lab space, administrative interns from the University of Texas, and funding to accelerate the venture. Eydis hopes to win MassChallenge in order to use cash prizes for clinical studies. Besides MassChallenge, DermaDiagnostics is actively seeking seed and angel funding at the moment.